A randomized, multi-center, open-label, phase III study of once-per-cycle DA-3031, a pegylated G-CSF, in comparison with daily filgrastim in patients receiving TAC chemotherapy for breast cancer

详细信息    查看全文

• 作者：K. H. Park ; S. Lee ; J. H. Park ; S. Y. Kang ; H. Y. Kim…
• 关键词：Breast cancer ; Pegylated G ; CSF ; TAC chemotherapy ; Neutropenia
• 刊名：Supportive Care in Cancer
• 出版年：2017
• 出版时间：February 2017
• 年：2017
• 卷：25
• 期：2
• 页码：505-511
• 全文大小：
• 刊物类别：Medicine
• 刊物主题：Oncology; Nursing; Nursing Research; Pain Medicine; Rehabilitation Medicine;
• 出版者：Springer Berlin Heidelberg
• ISSN：1433-7339
• 卷排序：25

文摘

PurposeThis multi-center, randomized, phase III study was conducted to demonstrate the non-inferiority of DA-3031 compared with daily filgrastim in patients during the first cycle of chemotherapy for breast cancer in terms of the duration of severe neutropenia (DSN).